Yesterdays email reply from Novus Capital re iTech float, posted for info:
"Mon 16/08/2021 3:18 PM
Dear Tommy,
There will be a Priority offer reserved for existing shareholders so you will have a chance to buy as many more as you would like in the float (assuming the priority offer is not in itself over subscribed). Of course you are also free to buy in the public offer as well.
The prospectus is being lodged today so it will formally open in 7 or 14 days depending on ASIC. You can read the Prospectus here but won’t be able to apply for shares until ASIC has done its work.
Kind Regards,
Gavan H Farley[
Director - Corporate Advisory"
Worth knowing, especially for those of us who want to make up a decent long term hold and marketable parcel, my gift is in the low $three figures.
- Forums
- ASX - By Stock
- AXE
- Ann: Update on iTech transaction
AXE
archer materials limited
Add to My Watchlist
0.00%
!
23.0¢

Ann: Update on iTech transaction, page-9
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
23.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $58.61M |
Open | High | Low | Value | Volume |
22.5¢ | 24.0¢ | 22.5¢ | $89.25K | 387.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 104441 | 23.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
23.5¢ | 56023 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 104441 | 0.230 |
8 | 182195 | 0.225 |
11 | 234057 | 0.220 |
7 | 58193 | 0.215 |
8 | 164657 | 0.210 |
Price($) | Vol. | No. |
---|---|---|
0.235 | 4141 | 1 |
0.240 | 101099 | 4 |
0.245 | 7000 | 1 |
0.250 | 76000 | 3 |
0.255 | 129000 | 3 |
Last trade - 16.10pm 27/06/2025 (20 minute delay) ? |
Featured News
AXE (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online